Veterinary Medicines

Chemistrin Forte 250.000 I.U./ml +250 mg/ml +0,5 mg/ml ενέσιμο εναιώρημα για βοοειδή και χοίρους

Authorised
  • Betamethasone sodium phosphate
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
Chemistrin Forte 250.000 I.U./ml +250 mg/ml +0,5 mg/ml ενέσιμο εναιώρημα για βοοειδή και χοίρους
Active substance:
  • Betamethasone sodium phosphate
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Betamethasone sodium phosphate
    0.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine
    250000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        74
        day
      • Milk
        6
        day
    • Pig
      • Meat and offal
        44
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RV01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 16955/02-04-2021/K-0186701
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 22/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."